Objectives: The aim of the study was to study antimicrobial susceptibility in Escherichia coli, Salmonella, Campylobacter and Enterococcus recovered from chickens, pigs and cattle using uniform methodology.
Introduction
The potential for transmission of antimicrobial-resistant enteric zoonotic bacteria from food animals to the human population has been a public health concern for several decades. Bacteria carrying antimicrobial resistance genes found in the intestinal tract of food animals can contaminate carcasses and may lead to food-borne disease that may not respond to antimicrobial treatment. Programmes to monitor zoonotic bacterial resistance are therefore essential. Various European countries have implemented national surveillance programmes (e.g. DANMAP, FARM, ITAVARM, MARAN, NORM-VET, SVARM, VAV) to assess susceptibility to antibiotics among enteric bacteria isolated from healthy animals. 1 -8 However, the results of these surveys are difficult to compare since there are differences between each national programme, e.g. sample collection, sample numbers, bacterial isolation and laboratory methodology. In some countries, resistance data are entirely lacking. Multinational surveillance studies are best carried out using standardized and uniform methods of sample collection, organism identification and antimicrobial susceptibility testing, 9 preferably by a single laboratory. 10 The present surveillance study is the second part (sampling period 2002 -03) of the European Antimicrobial Susceptibility Surveillance in Animals (EASSA), which was coordinated by the European Animal Health Study Centre (CEESA). The first part (sampling period 1999 -2001) has been reported previously. 11 The study was based on bacteria from healthy animals, and employed uniform methods of sampling and isolation, together with a single central laboratory for MIC determination for a panel of antimicrobials commonly used in human medicine. The procedures followed the recommendations of the OIE (World Organisation for Animal Health) guidelines. 9 The target organisms were Salmonella and Campylobacter species as zoonotic organisms, and commensal Escherichia coli and Enterococcus species as indicator organisms for Gramnegative and Gram-positive bacteria, respectively. Slaughter is potentially the most important time for contamination of carcasses and subsequently meat products, with intestinal bacteria, and therefore it is the most relevant point from which to obtain isolates for antibiotic susceptibility testing. Additionally, the prevalence of antibiotic-resistant bacteria represents the 'final outcome' (i.e. cumulative exposure to, and selection by, any antibiotic used during the life of the animal) that may be present to potentially enter the food chain. Faecal or caecal isolates as appropriate were collected from each of the major food animal species for three production categories: beef cattle, slaughter pigs and broiler chickens. Sampling of carcasses has been omitted because considerable cross-contamination in abattoirs has been described, which would bias the prevalence of the organisms on the farms and not reflect the susceptibility of isolates recovered from the individual animals. 12, 13 Materials and methods
Selection of countries and sample sites
Countries included in the programme (Table 1) were representative of major areas of farm animal production in the EU from Scandinavia in the north to Spain and Italy in the south. Five countries were selected per animal species (Table 1) . Responsibility for the identification of appropriate animal slaughter sites to provide samples for the isolation of target organisms was allocated to a single individual based within each participating country in collaboration with members of the national meat hygiene services. The national coordinators arranged for samples to be taken by standard procedures and transported to the national microbiology laboratories for bacterial isolation. The selected slaughterhouse sites were representative of animal production within individual countries in terms of animal throughput and geographical distribution. The numbers of slaughterhouses per country were 3 -8 for chickens, 4 -9 for pigs and 3 -8 for cattle.
Animal sampling procedures
Sampling was started in 2002 in different months per country, and samples were collected over a 1 year period in each country following the commencement of sampling resulting in a sampling period from Q1 2002 to Q4 2003. The targeted number of samples was 100 per country and per host. For broiler chickens, entire caeca were removed at slaughter and dispatched to microbiology laboratories where their contents were removed. For pigs and cattle, 5 g of content was aseptically removed from the large intestine after incision with a scalpel. All samples were taken, where possible, within 10 min of slaughter and held in sterile containers. A single bird or animal was selected at random as being representative of a flock or herd. As the prevalence of Salmonella appears to be particularly low, efforts were made to enhance their numbers by supplementation from the French and Spanish national collections, which fulfilled the selection criteria including the time period and collection sites. The actual numbers of isolates per country and per animal species as well as the total numbers per host are shown in Tables 1-5 .
Microbiological isolation and identification
Organisms were isolated by a single microbiology laboratory in each country, and the samples were collected under the supervision of one individual using standard microbiological procedures. The exceptions to this were Germany and France (two laboratories each) and Italy (four laboratories) where isolation was performed in laboratories local to the regions of sampling. One randomly selected isolate for each bacterial species was retained for each sample.
E. coli, Salmonella spp. and Campylobacter spp. were recovered and identified as described previously. 11 All Salmonella isolates were serotyped according to the Kauffmann -White scheme. Where applicable, phage typing was conducted. Identification of Campylobacter isolates to species level was based on the ability to hydrolyse sodium hippurate and indoxyl acetate, and also susceptibility to cefalotin. Isolates identified as non-Campylobacter jejuni or non-Campylobacter coli or C. jejuni and C. coli isolates showing unusual MIC patterns (e.g. resistance to nalidixic acid, yet full susceptibility to ciprofloxacin) were re-examined by multiplex PCR for identification of C. jejuni or C. coli and, in the case of non-C. jejuni/coli, by amplified fragment-length polymorphism (AFLP) typing. Recovery and identification of Enterococcus isolates were conducted by standard phenotypic methods, as described previously. 14 In brief, caecal/rectal contents were plated out on Slanetz and Bartley agar, a selective medium for enterococci, and incubated at 42+18C to increase selectivity. Presumptive enterococci were isolated from their morphologically characteristic colonies by standard methods. Up to three colonies presenting the typical shape and colour (e.g. for Enterococcus faecium relatively large colonies with de Jong et al.
a red centre and distinct white edge; for Enterococcus faecalis colonies with a red to deep maroon centre; for Enterococcus hirae small dark maroon colonies; for Enterococcus casseliflavus generally pale pink) were sub-cultured to purity and identified, but only one organism per sample was retained for the collection.
Isolates obtained at national microbiology laboratories were sent to the central laboratory (Charles River, Scotland, UK), which was the repository for the culture collection. Isolates were usually sent on dry ice, although some campylobacters were shipped on charcoal transport medium swabs at ambient temperature. Cultures were held at 2708C suspended in a growth medium with glycerol as cryopreservative until susceptibility testing was performed.
Antimicrobial susceptibility testing
All MIC testing was performed at the central laboratory. E. coli, Salmonella spp. and Enterococcus spp. were tested by standard agar dilution methods according to the recommendations of the CLSI (formerly the NCCLS) (M31-A2), 15 or according to M45-A for Campylobacter spp. 16 For all MIC tests, the presence or absence of growth was assessed using a 'Domino' image analysis system (Perceptive Instruments Ltd, Steeple Bumpstead, UK) running dedicated MIC test evaluation software. Reference standard bacterial strains were tested concurrently as controls, including the following: for tests with E. coli, Salmonella and Enterococcus, the quality control strains were E. coli ATCC 25922, Staphylococcus aureus ATCC 29213 and E. faecalis ATCC 29212; for tests with Campylobacter, C. jejuni ATCC 33560 was additionally included.
MICs of the following nine antibiotics were determined for E. coli isolates: ampicillin, cefepime, cefotaxime, ciprofloxacin, chloramphenicol, colistin, gentamicin, tetracycline and trimethoprim/ sulfamethoxazole. For MIC testing of Salmonella isolates, nalidixic acid, streptomycin and sulfisoxazole were added to this panel of antibiotics. MICs of the following five antibiotics were determined for Campylobacter: ciprofloxacin, erythromycin, gentamicin, nalidixic acid and tetracycline, and for the enterococci susceptibility was also determined to the following five antibiotics/antibiotic combinations: ampicillin, gentamicin, linezolid, quinupristin/dalfopristin and vancomycin. All antimicrobials were obtained from Sigma Chemical Co. MIC 50 and MIC 90 values, as well as rates of resistance, were calculated and presented. Since no noticeable differences were determined between slaughter sites within a given country, results were summarized by country. Resistance was assessed according to clinical breakpoints for Enterobacteriaceae and enterococci as defined by M100-S17, 17 and for Campylobacter as defined by M45-A (ciprofloxacin, erythromycin and tetracycline) 16 or M100-S17 (gentamicin and nalidixic acid). 17 Where there were no CLSI breakpoints published for a particular compound (streptomycin), those adopted by the US National Antimicrobial Resistance Monitoring System (NARMS) were used.
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For colistin, the breakpoint for Enterobacteriaceae recommended by Gales et al. 19 was applied.
Additionally, decreased susceptibility was determined for three 'lastline' antibiotics used to treat serious infections (cefotaxime, ciprofloxacin, erythromycin) based on epidemiological cut-off values as defined by the European Food Safety Authority (EFSA).
20
Two-sided x 2 tests were used for an overall comparison and, in the case of a significant difference, for pairwise comparisons of resistance prevalence (%) between countries and between animal species. Countries or animal species with ,15 isolates were not considered in the statistical analysis. A P value of 0.05 was considered as significant.
Results
In total, 1500 samples were investigated and 3173 isolates were available for testing. E. coli (Table 1) The isolation rate for E. coli approached 100%, in all hosts and countries with the exception of Spain (chickens). The total number of isolates for each host was close to 500.
Generally, the prevalence of resistance was markedly lower among cattle isolates than among either pig or chicken isolates. Resistance was highest to ampicillin, tetracycline and trimethoprim/sulfamethoxazole, ranging on average from 2.7% to 52.6%, 8.2% to 66.4% and 3.5% to 52.0%, respectively. Marked country differences were noted for all three antibiotics. For instance, in chickens, ampicillin resistance was clearly lower in France than in the Netherlands, Spain or the UK; prevalence of resistance was the highest in Germany (71%). In pigs, isolates from Spain showed the highest prevalence of resistance (53%). Resistance was much lower in cattle than in pigs and chickens, with 1% in Germany and Ireland and absent in France and the UK. Similarly, in samples from pigs, there was a variable rate of tetracycline resistance from 33% (Denmark) to 91% (France). The proportion of isolates of E. coli resistant to trimethoprim/ sulfamethoxazole from chickens in samples from France and Spain was lower than in the other countries sampled. For colistin and gentamicin, resistance was either absent or very low, but in chickens resistance to chloramphenicol-banned from use in food animals for many years in the EU-ranged from 6% in the UK to 24% in Spain.
Of the cephalosporins, clinical resistance was only encountered for cefotaxime in only two countries (Germany and the Netherlands) for two chicken isolates. Both isolates involved were phenotypically categorized as ESBL producers. Decreased susceptibility based on epidemiological cut-off values defined by EFSA was noted for 5.4% of the isolates. Ciprofloxacin MIC 90 was generally identical to MIC 50 (i.e. 0.016 mg/L) for cattle and pigs, but in chickens, increased MIC 90 values of 0.25 up to 8 mg/L (Spain) were observed; the prevalence of clinical resistance was similar among four countries (0% to 4%), but for the fifth country (Spain) the resistance was markedly higher (24%). In contrast, clinical resistance was absent among E. coli isolates from cattle and pigs with the exception of Italy (cattle 5%) and Spain ( pigs 2%). 
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Multiple resistance was defined as simultaneous resistance to at least four antimicrobials of different classes tested, with trimethoprim plus sulfamethoxazole considered as one unit since the testing was in combination. Taking all isolates of E. coli collected from the different countries into account, the most frequent phenotype was represented by resistance to ampicillin/ chloramphenicol/tetracycline/trimethoprim plus sulfamethoxazole (in 0.2% of cattle isolates, 6.7% of pig isolates and 6.6% of chicken isolates). Overall, seven isolates (0.5%) were resistant to five compounds and two isolates (0.1%) to six compounds.
Salmonella spp. (Table 2)
The overall isolation rate was low (mean 4.5%; ranging from 0% to 12%); Salmonella prevalence per animal species amounted to 1%, 5% and 8% for cattle, pigs and chickens, respectively. Where practicable the number was supplemented by adding numbers from the national collections (see above), but nevertheless numbers remained low and made comparisons difficult. In the case of chickens (France, the Netherlands and Spain), pigs (Denmark, Germany and the Netherlands) and cattle (all five countries), the small numbers precluded proper evaluation of susceptibility to antimicrobials. Hence, overall figures per host species (cattle, n ¼ 15; pigs, n ¼ 128; chickens, n ¼ 62) are presented, as well as the countries exhibiting Salmonella numbers exceeding 14 isolates (four countries; Table 2 ). In all, 205 isolates were serotyped, with at least one member of 31 Salmonella serotypes represented. The main serotypes found (excluding cattle since numbers were too small) were Salmonella Typhimurium (24% of the total, mostly pigs), Salmonella Derby (23%, virtually only pigs), Salmonella Indiana (12%, only chickens), Salmonella Rissen (9%, only pigs), Salmonella Brandenburg (3%, only pigs) and Salmonella Enteritidis (3%, only chickens). Other serotypes (26%) were present only in small numbers (n ¼ 1-5).
The picture for Salmonella differs from that of E. coli with the prevalence of resistance being most notable in the porcine isolates. The overall prevalence of ampicillin resistance in pigs was markedly higher than that for cattle and chickens. For the frequently detected individual serotypes, 51% of Salmonella Typhimurium were resistant to ampicillin (n ¼ 25), compared with 6% for Salmonella Derby (n¼ 3) and 0% for Salmonella Indiana (n ¼ 0). Resistance among pig isolates to sulfisoxazole and tetracycline was 57% and 79%, whereas it exceeded 20% for the other older molecules. In contrast, resistance to cattle and chicken isolates only exceeded 20% for sulfisoxazole and was usually clearly below 10% for the other tested antibiotics for both host species. Tetracycline resistance among countries varied from 3% (chicken isolates, Germany) to 96% ( pig isolates, Spain). Similarly, resistance prevalence to chloramphenicol was the highest in pigs. Resistance varied from 31% among isolates from pigs in Spain to 0% among isolates from chickens in Germany. Of the resistant isolates, 63% were Salmonella Typhimurium. For all hosts, very low rates of resistance to gentamicin were noted, whereas variable rates of colistin resistance were observed (albeit numbers were low).
Neither clinical resistance nor decreased susceptibility was seen for cefepime and cefotaxime. No clinical resistance to ciprofloxacin was seen in any of the isolates recovered from any of the countries, although 11% of the avian isolates exhibited a reduced susceptibility (MIC 0.12 mg/L). Resistance to nalidixic acid was usually ,10%. Of the countries with porcine isolates, Spain showed the highest resistance to nalidixic acid (10%). The isolates highly resistant to nalidixic acid (MICs . 128 mg/L) were identical to the isolates showing decreased susceptibility to ciprofloxacin (MICs 0.125 -0.25 mg/L). Moreover, two Salmonella Wien isolates were borderline resistant (MICs 32 mg/L) and exhibited ciprofloxacin MICs of 0.06 mg/L.
Multiple resistance was studied for the drugs with clinical relevance; the marker compounds nalidixic acid and streptomycin were excluded. Resistance to four or more drugs of different classes (11.2%) was seen in varying combinations; the most frequent combination was ampicillin/chloramphenicol/sulfisoxazole/ tetracycline (9.8%). Among pig isolates (Spain), the most common resistance phenotype was the combination of ampicillin/chloramphenicol/sulfisoxazole/tetracycline/trimethoprim plus sulfamethoxazole (4.4%).
Campylobacter spp. (Tables 3 and 4)
The isolation rate was variable, both for C. jejuni and C. coli and for all three host species. In broilers, the most frequently isolated species were C. jejuni (57%) and C. coli (43%). In cattle, 47% and 36% of the isolates were identified as C. jejuni and C. coli, respectively, but another 17% of the isolates were identified as Campylobacter fetus (n ¼16), Campylobacter hyointestinalis (n¼ 15) or Campylobacter-like organisms not conforming to recognized species descriptions (n ¼ 6). In contrast, 95% of the isolates from pigs were identified as C. coli, 2% as C. jejuni and 3% as Campylobacter spp. comprising C. hyointestinalis and a previously unknown Campylobacter species. For the five antibiotics tested, the prevalence of resistance was always higher among C. coli than C. jejuni. Antimicrobial patterns among the C. fetus and C. hyointestinalis were similar (data not shown). The antimicrobial susceptibility patterns presented (Tables 3 and 4) are limited to C. jejuni and C. coli, the major human pathogens, and countries from which ,10 isolates were recovered have been omitted.
None of the C. jejuni strains displayed resistance to erythromycin or gentamicin (Table 3 ). The highest prevalence of resistance of C. jejuni was towards ciprofloxacin, nalidixic acid and tetracycline. Spanish strains from chickens displayed the highest rates of resistance to ciprofloxacin (83%) and nalidixic acid (92%). With the exception of nalidixic acid (cattle) and tetracycline (chicken), C. jejuni isolates from the UK had the lowest resistance to all the antibiotics tested. In contrast, for C. coli, the prevalence of resistance was notably higher (Table 4) . Resistance to tetracycline exceeded 50% in C. coli for all three species. Ciprofloxacin resistance varied from 26% in cattle to 60% in chickens; nalidixic acid resistance in porcine C. coli isolates ranged from 7% (Denmark) to 90% (Spain). Erythromycin resistance was most notable in C. coli recovered from pigs at 33%, with country variations from 5% to 62%. Resistance to gentamicin was minimal. As applied for C. jejuni, isolates of C. coli from the UK usually had the lowest rate of resistance.
Multiple resistance to clinically relevant drugs (ciprofloxacin, erythromycin, gentamicin and tetracycline) was found at low frequency rates. Multiresistant isolates were absent for C. jejuni and amounted to 4.3% for C. coli, almost exclusively referring to porcine strains from Spain. Similarly, resistance to the combination ciprofloxacin/erythromycin/tetracycline refers to porcine C. coli (n ¼ 49; 14.1%), which also applies to the combination de Jong et al.
ciprofloxacin/erythromycin (n ¼6; 1.7%). The latter two phenotypes were absent for C. jejuni.
Enterococcus spp. (Table 5) Among the enterococci, E. faecium was the dominant species (50%) in all three hosts followed by Enterococcus durans (22%), E. faecalis (12%) and E. hirae (3%). For several species, considerable differences in recovery among the participating countries were observed. For the five antibiotics studied, the antimicrobial patterns of E. durans and E. hirae were comparable to those of E. faecium. The antimicrobial susceptibilities discussed below are limited to E. faecium and E. faecalis, the two major human pathogens. Countries from where the recovery rate was ,15 isolates have been omitted. Little or no resistance to ampicillin or gentamicin was observed for E. faecium strains. The overall resistance prevalence to ampicillin in pigs and chickens was 0.5% and 1.9%, respectively; in cattle, resistant isolates were absent. None of the E. faecalis isolates exhibited resistance to ampicillin. For gentamicin, one chicken strain of Spanish origin displayed high-level resistance. In contrast, 11% of the porcine E. faecalis isolates (Germany and Denmark) showed high-level resistance to gentamicin. The resistance prevalence to quinupristin/dalfopristin was variable. Overall resistance was close to 20% for pigs and chickens, but in cattle it was below 10%. Marked country differences were noted. Whereas resistance among pig isolates was low in the Netherlands and Spain (0% and 6%, respectively), in France 60% of the E. faecium isolates displayed resistance. With regard to chickens, again isolates from France showed the highest rate of resistance (37%) and markedly exceeded the resistance prevalence in the Netherlands and Spain. Resistance of E. faecalis was 75%, 83% and 100% for cattle, pig and chicken isolates, respectively (chicken isolates only n ¼ 6; data not shown). None of the E. faecium and E. faecalis strains was resistant to linezolid, but for vancomycin the overall rate of resistance was 2% to 4%. For E. faecalis, one cattle isolate was resistant, but none of the porcine or avian isolates.
E. faecium showed a high level of susceptibility to four compounds tested, and hence multiresistance was absent. Only resistance to quinupristin/dalfopristin was considerable and varied from 8% to 20% per host species. The low numbers of E. faecalis precluded any conclusions on multiple resistance. de Jong et al.
Discussion
Resistance among bacteria isolated from food animals is a potential hazard in that the resistance may occur in zoonotic pathogens and so potentially reduce the effectiveness of antimicrobial treatment of food-borne disease if contracted by humans. The degree of risk posed by this hazard is difficult to estimate, partly because there is a shortage of information regarding the resistance prevalence among bacterial isolates from foodproducing animals, coupled with inadequate information on both the international distribution and trends of resistance. Although national monitoring programmes have been introduced in a number of countries, differences in methodologies make it difficult to compare results from one programme with another. It is important to know both the prevalence and trends in antibiotic resistance as such information, together with comparisons of antibiotic use practices between countries, may indicate the best approach to control resistance. The EASSA programme described here, by being international and longitudinal in its surveillance of bacteria from farm animals, is exceptional. The organisms isolated were Salmonella spp., Campylobacter spp., Enterococcus spp. and E. coli. The inclusion of Enterococcus spp. represented a change from the earlier sampling, 11 but this organism was considered sufficiently important for inclusion in the programme. The antimicrobials chosen include those of importance to human medicine, as well as some antimicrobials used in food-producing animals. The E. coli results allowed for comparisons between species, countries and antimicrobial agents owing to the predictably high recovery rate. Comparing different antimicrobial agents, the resistance prevalence was higher among older compounds notably ampicillin, tetracycline and trimethoprim/sulfamethoxazole while much lower for the newer compounds cefepime, cefotaxime and ciprofloxacin. Colistin ( polymyxin E), although by no means a modern compound, was nevertheless almost universally effective against the E. coli isolates tested. Resistance to chloramphenicol was surprisingly high in pigs and chickens in view of the absence for many years of chloramphenicol as a therapeutic agent. The explanation is probably a linked resistance factor to another compound. For cattle, isolates from Italy tended to show higher resistance than those from Germany, France, Ireland or the UK. For pigs, isolates from Spain generally showed higher resistance than those from Germany, France, Denmark or the Netherlands. In our earlier report, 11 Spain was also identified as having a higher prevalence of resistance than the countries with which it was compared. In the case of isolates from chickens, there was, apart from ciprofloxacin (Spain), no obvious and consistent difference between E. coli from the different countries sampled.
Resistance among Salmonella isolates followed similar variation between countries to that seen for E. coli, but the low rate of recovery (even with some supplementation) limited the opportunity to make comparisons between countries. This supported the use of E. coli as an indicator organism for resistance in the field. Nalidixic acid was included as an indicator of a shift in the ciprofloxacin MIC away from fully susceptible wild-type populations. Spain was again the country showing the most marked reduction in susceptibility among pig isolates (including 10% nalidixic acid resistance). The presence of nalidixic acid resistance among Salmonella strains may suggest that fluoroquinolone resistance, although largely absent based on the selected clinical breakpoint, is a potential emerging issue. However, clinical resistance to fluoroquinolones has rarely emerged, 21, 22 presumably due to the prohibitive fitness costs of the resistant organisms. This illustrates the contrast between the epidemiological cut-off value and the clinical breakpoint 23, 24 where the former can indicate an emerging decrease in susceptibility, while the latter allows clinical efficacy to be predicted from the MIC determination.
CLSI clinical breakpoints were primarily used in the present paper rather than epidemiological cut-off values. However, it is important to consider the population of isolates with decreased susceptibility. In particular, this applies to antimicrobial agents essential for human and veterinary medicines such as fluoroquinolones, cephalosporins and macrolide antimicrobials. 25 Recently, the EFSA has set epidemiological cut-off values for various antimicrobials for Salmonella spp. and C. jejuni and C. coli. 20 For these organisms (except C. coli because erythromycin breakpoints and cut-offs are identical) and for E. coli, we determined the percentage decreased susceptibility when compared with the clinical resistance for some critically important antimicrobial agents (Table 6 ). For cefotaxime, significant differences between the two populations were usually absent, but in E. coli from chickens a tendency for increased numbers of isolates with decreased susceptibility was apparent, including 10 ESBLs out of 26 strains. Currently, these strains are being genotypically characterized. Similarly, for ciprofloxacin, a decreased susceptibility clearly emerged in chicken isolates. Decreased susceptibility to fluoroquinolones has been associated with decreased clinical responses of Salmonella infections to fluoroquinolones. 26, 27 However, part of the evidence is based on single cases 26 or infections with multiresistant salmonellae. 27 It should, however, be noted that similar reductions in treatment efficacy have been observed in studies with multiresistant Salmonella isolates, albeit their full susceptibility to quinolones. 28, 29 Hence, marked differences are apparent, which demonstrates the relevance of applying both epidemiological cut-off values and clinical resistance breakpoints in surveillance programmes such as the present one. Application of only clinical breakpoints can mask important shifts in MICs towards a less susceptible population. Conversely, and regrettably, a few national surveys 1, 4 have recently introduced the application of epidemiological cut-off values in isolation, thus missing the opportunity to characterize and separate both populations. This approach can cause confusion, particularly among clinicians-the potential target of such surveys-who are likely to interpret the term 'resistant' as 'clinically resistant', and not, as may be the case, 'less susceptible but nevertheless clinically susceptible'.
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A number of species of Campylobacter were identified, but the results and discussion will be limited to the two species particularly associated with human health, namely C. jejuni and C. coli. Campylobacter infection in humans remains a common occurrence, although the prevalence appears to have fallen in recent years, at least in the UK. 31 In C. jejuni (isolates were only available for cattle and chickens), resistance varied between countries for both nalidixic acid and ciprofloxacin, and, as expected, nalidixic acid resistance corresponded quite closely with that to ciprofloxacin. Isolates from chickens in Spain showed 92% resistance to nalidixic acid and 83% resistance to ciprofloxacin. However, the UK chicken isolates showed 13% resistance to nalidixic acid and 11% resistance to ciprofloxacin. Erythromycin and gentamicin resistances were absent in C. jejuni isolates from both cattle and chickens, while tetracycline resistance was variable and generally rather high. For C. jejuni, notable differences between the clinically resistant and the decreased susceptibility population were absent for erythromycin; the proportion of isolates with decreased susceptibility to ciprofloxacin was negligible (Table 6 ). C. coli isolates were available from cattle, pigs and chickens in sufficient numbers to allow comparison. Results were generally similar to those for C. jejuni where comparison was possible. The inclusion of pigs showed that this species appeared to carry more resistant isolates, particularly to erythromycin. The use of the macrolide tylosin may have accounted for this. 32 On the other hand, it should be recognized that the prevalence of C. coli in pork is extremely low 33 and retail pork is not considered to be a sufficiently significant source of Campylobacter to cause human campylobacteriosis in industrial countries.
In contrast to the report of an earlier sample point in the EASSA programme, 11 enterococci were sampled in this study as an indicator organism for Gram-positive bacteria, although enterococcal infections, especially E. faecium, are also of increasing importance. 34 E. faecium was the species recovered most frequently (50% of total enterococci isolated), while E. faecalis was isolated markedly less frequently (12%). Only a few E. faecium and none of the E. faecalis isolates displayed resistance to ampicillin. None of the E. faecium and E. faecalis strains was resistant to linezolid, as might be expected since no related compound has been used in animals. Resistance of E. faecium to quinupristin/ dalfopristin was variable, and surprisingly high in view of the fact that no related compound is now permitted for animal use in the EU, although prior to 1999 another streptogramin, virginiamycin, was used as a growth promoter. Overall, resistance was higher in pigs and chickens than in cattle, perhaps reflecting the former use of virginiamycin in those species. In the case of some of the countries sampled, it was possible to compare the present results with those obtained (in a separate CEESA study) some years earlier 14 at the time of the virginiamycin growth promotion ban. In fact, over this period, the quinupristin/dalfopristin resistance had not declined appreciably, and, in some countries, even appeared to have increased slightly. This disappointing observation may be explained by linked resistance to compounds that are used to treat clinical disease in pigs and chickens. E. faecalis showed high resistance to quinupristin/dalfopristin, but this is expected since this organism is intrinsically resistant to streptogramins. The overall rate of resistance to vancomycin was 2% to 4% and had not declined markedly since the earlier sampling 14 although the use of the related compound avoparcin had been banned from use in animals some 6 years earlier. It appears that the removal of an antibacterial compound from use in food animals does not lead to prompt elimination of resistant bacteria in those animals, although some decline has been reported elsewhere (DANMAP) following such removal, albeit the decline was seldom completely to zero.
One objective of this study was to make international comparisons and, despite the variations, some differences emerged. One reasonably consistent observation was the relatively lower occurrence of resistance seen in more northern, especially Scandinavian, countries. Conversely, in a number of cases Spain emerged as the country with the higher incidence of resistance. The reasons for this are not entirely apparent; one possibility is that regulations regarding veterinary antimicrobial prescription may be more rigorously enforced in northern countries, but another reason for their lower resistance levels could then be the less intensive agriculture in northern EU countries, with greater distances between livestock units, which decreases disease transmission. In this respect, availability of national consumption data for all EU countries, categorized per animal species, would be very helpful. Further studies are needed to shed light on any apparent differences in antimicrobial resistance between countries within the EU.
